1. Avery, G.S. (1973): Check-list to potential clinically important interactions. Drugs 5, 187–211.
2. Azarnoff, D.L. (1974): Drug interactions: clinical significance. Clin. Pharmacol. Ther. 16, 986.
3. Ballek, R.E., et al. (1966): Lancet ii, 1227.
4. Barar, F. S.K., Boakes, A.J., Benedikter, L.B., Laurence, D.R., Prichard, B.N.C., Teoh, P.C. (1971): Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man. Br. J. Pharmacol. 43, 472.
5. Boakes, A.J., Laurence, D.R., Teoh, P.C., Barar, F.S.K., Benedikter, L.T. (1973): Interactions between sympathomimetic amines and antidepressant agents in man. Br. Med. J. 1, 311.